Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Directorate Change

18 Jun 2009 11:33

RNS Number : 1146U
T2 Income Fund Limited
18 June 2009
 



T2 Income Fund Limited ("T2" or the "Company")

 

Appointment of new director and other board changes

The Company announces that the appointment of Mr Geoff Miller as a non-executive director of the Company and the resignation of each of William Tozier, Saul Rosenthal and Patrick Conroy from the board of directors of the Company take effect from today

Contrary to the statement contained in the Company's announcement of 1 June 2009, the appointment and retirement of directors from the board of the Company does not require approval or a statement of no objection from the Guernsey Financial Services Commission.

For further information, please contact:

Geoffrey Miller

T2 Income Fund Limited

+44 7785 374247 or +79 629 869471

Jonathan Cohen

Saul RosenthalT2 Advisers LLC

+1 203 983 5275

Philip Secrett

Nominated Adviser

Grant Thornton UK LLP

+44 (0) 207 383 5100

Michael Wentworth-Stanley

JP Morgan Cazenove

+44 (0) 207 588 2828

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABGGDLDXBGGCI

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.